Winslow, Evans & Crocker, Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$32,964,000
-2.5%
1,7580.0%0.01%0.0%
Q4 2017$33,824,000
+7.7%
1,7580.0%0.01%
+10.0%
Q3 2017$31,416,000
+0.1%
1,7580.0%0.01%
+11.1%
Q2 2017$31,398,000
+23.2%
1,7580.0%0.01%
+12.5%
Q1 2017$25,492,000
-21.3%
1,7580.0%0.01%
-20.0%
Q4 2016$32,384,000
-51.4%
1,758
-13.9%
0.01%0.0%
Q3 2016$66,700,000
+440.9%
2,042
+166.6%
0.01%
+150.0%
Q2 2016$12,332,0007660.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders